Skip to Content

Spritam Approval History

FDA Approved: Yes (First approved August 3, 2015)
Brand name: Spritam
Generic name: levetiracetam
Dosage form: Tablets
Company: Aprecia Pharmaceuticals Company
Treatment for: Seizures, Epilepsy

Spritam (levetiracetam) is a 3D printed drug product used as adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy.

Development History and FDA Approval Process for Spritam

DateArticle
Aug  3, 2015Approval FDA Approves Spritam (levetiracetam) as the First 3D Printed Drug Product

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide